Buy Sun Pharmaceutical Industries, target Rs 458: Kunal Bothra
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 458.0 and a stoploss at Rs 425 from entry point.
What’s going on in the equity markets?
There’s bad business news wherever one looks, writes Dhirendra Kumar.
Pharma wants a booster fund to push innovation
Indian Pharmaceutical Alliance seeks to promote innovation backed by risk capital.
Dow posts biggest one-day drop since October as recession fears take hold
The US yield curve has inverted before every recession in the past 50 years.
Sun Pharma to make upfront payment worth Rs 2.40 bn to CSIR-IICT Hyderabad for new drug compounds
This collaboration with CSIR-IICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline.
Do a staggered purchase and keep your shopping list ready: Arun Thukral, Axis Sec
FIIs have been flip-flopping and will return once growth becomes visible.
Real activity will start from Q4 of this year: Glenn Saldanha, Glenmark
From here on, the US sales should grow back and start trending upwards.
Is Sun Pharma on the road to recovery?
Sun Pharma’s consolidated net sales grew 16 per cent on back of favourable growth.
Tuesday’s selloff signals pain in Indian stocks may intensify
On Tuesday, largecaps such as Bajaj Finance, L&T and HDFC witnessed selling pressure.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service